(Circulation. 1997;96:834-841.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Cardiology, Hippokration Hospital, University of Athens, Greece.
Correspondence to Michael Kyriakidis, MD, 139-143 Karaiskou St, Piraeus 18535, Greece.
Background In this study, we both investigated coronary flow velocity in hypertrophic obstructive cardiomyopathy (HOCM) and tested the hypothesis of differing coronary flow reserve (CFR) of coronary arteries perfusing left ventricular regions with nonuniform myocardial hypertrophy by measuring the relative CFR.
Methods and Results Coronary flow velocity was assessed in left anterior descending coronary (LAD) and left circumflex (LCx) arteries in 18 patients with HOCM and marked hypertrophy only in the ventricular septum, in 13 patients without obstruction (HCM), and in 9 age- and sex-matched normal subjects at rest, during rapid atrial pacing, and after dobutamine infusion (5 to 30 µg/kg per minute). Relative CFR was estimated as the ratio between absolute CFR of the LAD and absolute CFR of the LCx (LAD/LCxCF). At the peak of rapid atrial pacing and during dobutamine stress, LAD/LCxCF was reversed in HOCM patients (from 1.25±0.11 to 0.82±0.07 and 0.79±0.06, respectively), whereas it remained unchanged in control subjects (from 1.0±0.1 to 1.0±0.05 and 1.0±0.05, respectively; P<.001). In HCM patients, LAD/LCxCF at rest was 1.10±0.11, whereas during rapid atrial pacing and dobutamine stress, it was 0.92±0.08 and 0.90±0.09, respectively. Relative CFR was 0.62±0.05 in HOCM patients and 1.05±0.05 (P<.001) in normal subjects. There was an inverse correlation between relative CFR and peak systolic outflow tract gradient (r2=.74, P<.001).
Conclusions Regional distribution of hypertrophy in some patients with HOCM resulted in regional impairment of coronary flow. Relative CFR can be used to estimate regional disturbances of coronary flow and may help in patient selection for new interventional therapeutic techniques.
Key Words: hypertrophy microcirculation blood flow cardiomyopathy
This article has been cited by other articles:
![]() |
S. A. Mohiddin, D. Begley, J. Shih, and L. Fananapazir Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
P P. Dimitrow, M Krzanowski, R Nizankowski, A Szczeklik, and J S Dubiel Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy Heart, March 1, 2000; 83(3): 262 - 266. [Abstract] [Full Text] |
||||
![]() |
K. L. Butler, A. H. Huang, and J. K. Gwathmey AT1-receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2482 - H2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. van Liebergen, J. J. Piek, K. T. Koch, R. J. de Winter, and K. I. Lie Immediate and Long-Term Effect of Balloon Angioplasty or Stent Implantation on the Absolute and Relative Coronary Blood Flow Velocity Reserve Circulation, November 17, 1998; 98(20): 2133 - 2140. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |